Enveric Biosciences Stock Forecast - Price Action Indicator
| ENVB Stock | USD 3.49 0.94 21.22% |
Enveric Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Enveric Biosciences stock prices and determine the direction of Enveric Biosciences's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Enveric Biosciences' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the RSI of Enveric Biosciences' share price is approaching 42 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Enveric Biosciences, making its price go up or down. Momentum 42
Sell Extended
Oversold | Overbought |
Wall Street Target Price 10 | Quarterly Revenue Growth (0.07) |
Using Enveric Biosciences hype-based prediction, you can estimate the value of Enveric Biosciences from the perspective of Enveric Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
Enveric Biosciences after-hype prediction price | USD 3.49 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Enveric Biosciences to cross-verify your projections. Enveric Biosciences Additional Predictive Modules
Most predictive techniques to examine Enveric price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Enveric using various technical indicators. When you analyze Enveric charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| 0.15 | (0.51) |
| Check Enveric Biosciences Volatility | Backtest Enveric Biosciences | Information Ratio |
Enveric Biosciences Trading Date Momentum
| On January 28 2026 Enveric Biosciences was traded for 3.49 at the closing time. The top price for the day was 3.67 and the lowest listed price was 3.40 . The trading volume for the day was 255 K. The trading history from January 28, 2026 did not affect price variability. The overall trading delta against the current closing price is 3.44% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Enveric Biosciences to competition |
Other Forecasting Options for Enveric Biosciences
For every potential investor in Enveric, whether a beginner or expert, Enveric Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Enveric Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Enveric. Basic forecasting techniques help filter out the noise by identifying Enveric Biosciences' price trends.Enveric Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Enveric Biosciences stock to make a market-neutral strategy. Peer analysis of Enveric Biosciences could also be used in its relative valuation, which is a method of valuing Enveric Biosciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Enveric Biosciences Market Strength Events
Market strength indicators help investors to evaluate how Enveric Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Enveric Biosciences shares will generate the highest return on investment. By undertsting and applying Enveric Biosciences stock market strength indicators, traders can identify Enveric Biosciences entry and exit signals to maximize returns.
| Accumulation Distribution | 18761.47 | |||
| Daily Balance Of Power | (3.48) | |||
| Rate Of Daily Change | 0.79 | |||
| Day Median Price | 3.54 | |||
| Day Typical Price | 3.52 | |||
| Price Action Indicator | (0.51) | |||
| Period Momentum Indicator | (0.94) | |||
| Relative Strength Index | 42.29 |
Enveric Biosciences Risk Indicators
The analysis of Enveric Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Enveric Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting enveric stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.12 | |||
| Standard Deviation | 13.54 | |||
| Variance | 183.24 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Enveric Biosciences
The number of cover stories for Enveric Biosciences depends on current market conditions and Enveric Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Enveric Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Enveric Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Enveric Biosciences Short Properties
Enveric Biosciences' future price predictability will typically decrease when Enveric Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Enveric Biosciences often depends not only on the future outlook of the potential Enveric Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Enveric Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 41.9 K | |
| Cash And Short Term Investments | 2.2 M |
Check out Historical Fundamental Analysis of Enveric Biosciences to cross-verify your projections. For information on how to trade Enveric Stock refer to our How to Trade Enveric Stock guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enveric Biosciences. Projected growth potential of Enveric fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Enveric Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (119.64) | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets | Return On Equity |
Understanding Enveric Biosciences requires distinguishing between market price and book value, where the latter reflects Enveric's accounting equity. The concept of intrinsic value—what Enveric Biosciences' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Enveric Biosciences' price substantially above or below its fundamental value.
It's important to distinguish between Enveric Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Enveric Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Enveric Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.